![]() |
Registered Charity No. 1060134 |
CME Course |
DIALYSIS ACCESS

The Old Town, Stockholm
May 10, 2008 - 12:00-16:00 |
Stockholm, Sweden |
ERA-EDTA CME Activities |
Chair-person: R. Coppo (Italy) |
Secretary: A.L.M. De Francisco (Spain) |
Members: J. Floege (Germany) |
R. Vanholder (Belgium) |
A. Wiecek (Poland) |
C. Zoccali (Italy) |
J. Cannata-Andia, ERA-EDTA President (Spain) |
CME Courses Coordinators: |
Basic Science and Clinical Nephrology: R. Coppo (Italy) and P. Ronco (France).
|
Chronic Renal Failure, Hypertension and Clinical Epidemiology: C. Zoccali (Italy) and G. London (France). |
Dialysis: R. Vanholder (Belgium), S. Davies (UK) and C. Wanner (Germany). |
Transplantation: C. Ponticelli (Italy) and J. Grinyo (Spain). |
Collaboration with ISN for courses in Eastern Europe: N. Lameire (Belgium), A. Covic (Romania). |
Chairman: Jan Tordoir, Maastricht (The Netherlands)
Information and registration
Participation is free of charge but is open only to delegates registered in the Congress.
If you have pre-registered to the Congress, you can participate in the Courses by simply downloading the form and send it by fax to +39-0521-959242 or by email to registrations@era-edta.org within and no later than April 7, 2008.
If you haven’t pre-registered, you can do it online at www.eraedta2008.org/registrations2008.htm within and no later than April 7, 2008. After April 7, 2008 you will have the possibility of registering onsite, first for the Congress and thus after also for the Course, directly on May 10 starting at 8.00. Admission to the Course is limited to the seating capacity of the lecture hall, thus "first come first served" basis will be applied.
Course participants will be awarded UEMS credits (convertible in AMA credits).
A coloured sticker will be attached to your badge at the entrance of the hall of the CME Course chosen and will entitle entrance to that course only.
COURSE PROGRAMME
| Vascular Access Use and Outcomes: An International Perspective From the DOPPS, B. Canaud, Montpellier (France) |
Intervention for nonmatured arteriovenous fistulae: L. Duijm, Eindhoven (The Netherlands) |
| All autogenous fistulae strategy. Is it possible?: C. Gibbons, Swansea (UK) |
| Cannulation of dialysis access. Which is the best method?: M. van Loon, Maastricht (The Netherlands) |
Virtual simulation to improve vascular access outcome: J. Tordoir, Maastricht (The Netherlands) |